Biocon Reports 355 Crore Rupees Consolidated Net Profit For Q2
Biocon Reports 355 Crore Rupees Consolidated Net Profit For Q2
Net profit grew whopping on account of strong top line, including biosimilar Pegfilgrastim sales in the US and margin expansion.
The blue-chip scrip of Rs 5 face value lost Rs 24.60 per share on BSE on Thursday.
